- Stocks Telegraph
- Posts
- 30 Nov - Morning Newsletter (with changes)
30 Nov - Morning Newsletter (with changes)
4 Skyrocketing Stocks To Trade Today
Good Morning!
November 29, 2021, American stock markets showed positive dynamics: the S&P 500 rose 1.32% to 4655 points, the Nasdaq rose 1.88%, the Dow Jones added 0.68%. All sectors closed in positive territory. Issuers from the technology industry (+ 2.64%) outperformed others on the back of rising quotations of chip manufacturers, a consumer goods company (+ 1.63%) on the back of an increase in retail sales last Friday, and utilities (+1, 57%).Company news
Quotes of Adagio Therapeutics (ADGI, + 86.43%) jumped sharply after the company announced that ADG20 antibodies are capable of fighting the omicron strain.
The release of the Moderna vaccine (MRNA, + 11.7%) against the new variant of the coronavirus is scheduled for early 2022.
Hertz Global (HTZ, + 6.0%) Board of Directors approved a $ 2 billion share buyback.
Despite concerns about the new covid-19 strain, US consumers were actively purchasing Black Friday products last week. According to Adobe, online sales on November 26, 2021 are $ 8.9 billion versus last year's $ 9 billion. Cyber Monday (November 29), the largest online shopping day of the year, is estimated to generate $ 10.2 billion to $ 11.3 billion in revenue from sales. Sensormatic Solutions reports that store traffic grew 47.5% year-over-year, but is still 28.3% lower than its pre-pandemic level in 2019.
5 Top Small Cap Value Stocks to Consider Right Now
Some of the greatest opportunities can be found in small cap value stocks.
Remember, even Amazon was once a $7 stock.
Tesla once had a market cap of just over a billion. While small caps do carry risk like every other stock, find the right one, and the rewards can be off the charts.
Today Top Movers
Cumberland Pharmaceuticals Inc. (CPIX) stock soared 111.82% to $4.66 in the pre-market trading after declaring that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor, to now include use in pre-operative administration.
Athersys Inc. (NASDAQ: ATHX) shares are trading up 29.41% at $1.32 at the time of writing following the announcement from the company that a manuscript reporting data from the Company’s MUST-ARDS clinical trial have been published in the peer-reviewed journal Intensive Care Medicine.
ERYTECH Pharma S.A. (ERYP) grew over 52.4% at $3.65 in pre-market trading today. The company recently announced the granting of US patent 11,141,468, covering methods of treating solid tumors by administering methioninase and asparaginase.
ImmunoGen Inc. (IMGN) stock moved up 14.53 percent to $5.44 in the pre-market trading after declaring positive top-line results from Pivotal SORAYA trial of Mirvetuximab Soravtansine in Ovarian Cancer.
US Govt. Injects $100's of Millions Into Lithium
The government's cash infusion could send lithium exploration companies soaring. They're desperate for new lithium mines to end China's Lithium Monopoly. See how you could take advantage of this enormous cash infusion.
Top Upgrades & Downgrades
JP Morgan turned bullish on PetroChina Company Limited (PTR), upgrading the stock to "Overweight" from Underweight.
Square Inc. (SQ) has won the favor of BofA's equity research team. The firm upgraded the shares from Underperform to Neutral and moved their price target to $221.00, suggesting 3.87% additional upside for the stock.
Tronox Holdings plc (TROX) received an upgrade from analysts at UBS. They changed their rating on TROX to Buy from Neutral in a recently issued research note.
Earlier Tuesday Wells Fargo reduced its rating on Falcon Minerals Corporation (FLMN) stock to Equal-Weight from Overweight and assigned the price target to $7.
Goldman Sachs analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Dollar Tree Inc. (DLTR) has been changed to Neutral from Buy and the new price target is set at $150.
Analysts at Jefferies downgraded Sigilon Therapeutics Inc. (SGTX)'s stock to Hold from Buy Tuesday.
$0.25 Uranium Stock Controls Key Canadian Assets as Uranium Soars
Small-cap Uranium stocks are soaring. Most have already doubled as Uranium cranks higher. But that's nothing compared to the gains ahead in the new Uranium bull market. The last time we saw something like this, well-positioned investors made 10X, 100X and up to 1,000X their money. We've uncovered the top $0.25 Uranium stock for 2021-22 riches.
Latest Insider Activity
Cisco Systems Inc. (CSCO) Chair and CEO Robbins Charles announced the sale of shares taking place on Nov 24 at $55.45 for some 162,959 shares. The total came to more than $9.04 million.
FuelCell Energy Inc. (FCEL) EVP, CFO & Treasurer Bishop Michael S. sold on Nov 24 a total 22,761 shares at $9.24 on average. The insider’s sale generated proceeds of almost $55440.0.
Delta Air Lines Inc. (DAL) Director Taylor David S declared the purchase of shares taking place on Nov 26 at $35.96 for some 6,000 shares. The transaction amount was around $0.22 million.
Cleveland-Cliffs Inc. (CLF) EVP, CFO Goncalves Celso L Jr bought on Nov 29 a total of 78,921 shares at $21.18 on average. The purchase cost the insider an estimated $105,895.
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing
The White House is scared of our country's lithium supply running out. That's why Biden issued executive order 14017 to figure out how to expand our lithium production. And this is GREAT news for one company who's gobbling up land in the lithium-rich Nevada desert.
Important Earnings
Top US earnings releases scheduled for today include Zscaler Inc. (NASDAQ:ZS). It will announce its Oct 2021 financial results. The company is expected to report earnings of $0.12 per share from revenues of $208.43M in the three-month period.
Analysts expect salesforce.com inc. (NYSE:CRM) to report a net income (adjusted) of $0.92 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Oct 2021 is predicted to come in at $6.8B.
NetApp Inc. (NTAP), due to announce earnings after the market closes today, is expected to report earnings of $1.21 per share from revenues of $1.55B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.